Members |
targetComponentId |
Medicinal product acting as phosphorus supplement (product) |
Phosphorus supplement |
Medicinal product acting as potassium supplement (product) |
Potassium supplement (substance) |
Medicinal product acting as potassium-sparing diuretic (product) |
Potassium-sparing diuretic (substance) |
Medicinal product acting as pyridoxine supplement (product) |
Vitamin B6 supplement (substance) |
Medicinal product acting as retinol supplement (product) |
Vitamin A supplement (substance) |
Medicinal product acting as riboflavin supplement (product) |
Riboflavin supplement (substance) |
Medicinal product acting as saluretic (product) |
Diuretic (substance) |
Medicinal product acting as scabicide agent (product) |
Scabicide |
Medicinal product acting as sedative (product) |
Sedative (substance) |
Medicinal product acting as selenium supplement (product) |
Selenium supplement (substance) |
Medicinal product acting as sodium supplement (product) |
Sodium supplement (substance) |
Medicinal product acting as sulfur supplement (product) |
Sulfur supplement (substance) |
Medicinal product acting as thiamine supplement (product) |
Thiamine supplement |
Medicinal product acting as thrombolytic agent (product) |
Thrombolytic agent (substance) |
Medicinal product acting as uricosuric (product) |
Uricosuric agent (substance) |
Medicinal product acting as vasoconstrictor (product) |
Vasopressor |
Medicinal product acting as vasodilator (product) |
Vasodilator (substance) |
Medicinal product acting as vasopressor (product) |
Vasopressor |
Medicinal product acting as vitamin supplement (product) |
Vitamin supplement (substance) |
Medroxyprogesterone 5mg / Conjugated Estrogens 625microgram tablet |
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) |
Medroxyprogesterone acetate 104mg injection suspension 0.65mL prefilled syringe |
Medroxyprogesterone acetate 160 mg/mL suspension for injection |
Medullary carcinoma with amyloid stroma |
Medullary carcinoma with amyloid stroma |
Medulloblastoma, no International Classification of Diseases for Oncology subtype |
Medulloblastoma |
Mefloquine hydrochloride 250mg tablet |
Product containing precisely mefloquine (as mefloquine hydrochloride) 250 milligram/1 each conventional release oral tablet (clinical drug) |
Megaconial myopathy |
A rare genetic, skeletal muscle disease with characteristics of early-onset hypotonia, muscle weakness, global developmental delay with intellectual disability and cardiomyopathy. Congenital structural heart defects and ichthyosiform cutaneous lesions have also been associated. Muscle biopsy shows characteristic enlarged mitochondria located at the periphery of muscle fibres. |
Megakaryoblast |
Megakaryoblast |
Megakaryocyte |
Megakaryocyte |
Megaloblastic anaemia NOS |
Megaloblastic anemia |
Megaloblastic anemia NOS |
Megaloblastic anemia |
Megarectum |
Acquired megacolon |
Meglumin iotroxinate |
Product containing iotroxic acid (medicinal product) |
Meglumine iothalamate 60% infusion solution vial |
Iothalamate only product |
Melanocytic nevus - category |
Pigmented nevus |
Melanoma in situ by body site |
Melanoma in situ |
Melanoma vaccine |
Vaccine product |
Melanoma vaccine |
Vaccine product |
Melanoma: [skin] or [malignant] |
Malignant melanoma |
Melanoma: [skin] or [malignant] |
Malignant melanoma |
Melanotic neuroectodermal tumor of infancy |
Melanotic neuroectodermal tumor of infancy |
Melasian type |
Melasian type |
Memantine 2mg/mL oral solution |
Memantine hydrochloride 2 mg/mL oral solution |
Member of self-help group NOS |
Member of self-help group |
Member of self-help group NOS |
Member of self-help group |
Membrane metallo-endopeptidase |
Lymphocyte antigen CD10 |
Memory disturbance (& amnesia (& symptom)) |
Memory impairment (finding) |
Memory impairment |
Memory impairment (finding) |
Meningeal neoplasm, uncertain whether benign or malignant |
Meningioma of uncertain behavior (morphologic abnormality) |
Meningioma, benign, no International Classification of Diseases for Oncology subtype |
Benign meningioma |
Meningococcal antibody |
Neisseria meningitidis antibody |
Meningococcal polysaccharide vaccine adverse reaction |
Adverse reaction to component of vaccine product containing Neisseria meningitidis antigen (disorder) |
Meniscus derangement NOS |
Derangement of meniscus |
Meniscus derangement NOS |
Derangement of meniscus |
Menopausal &/or postmenopausal disorders |
Disorder associated with menstruation AND/OR menopause |
Menopausal and postmenopausal disorders |
Disorder associated with menstruation AND/OR menopause |
Menopausal and postmenopausal disorders |
Disorder associated with menstruation AND/OR menopause |
Menopause monitoring NOS |
Menopause monitoring (regime/therapy) |
Menopause monitoring NOS |
Menopause monitoring (regime/therapy) |
Menstrual data NOS |
Menstrual data |
Menstrual data NOS |
Menstrual data |
Menstruation disorder NOS |
Disorder of menstruation (disorder) |
Menstruation disorder NOS |
Disorder of menstruation (disorder) |
Menstruation disorder NOS |
Disorder of menstruation (disorder) |
Mental &/or developmental handicap screen |
Screening for developmental disorder (procedure) |
Mental &/or developmental handicap screen |
Screening for developmental disorder (procedure) |
Mental Health Act examination NOS |
Mental Health Act examination (procedure) |
Mental Health Act examination NOS |
Mental Health Act examination (procedure) |
Mental disorder - unspecified whether during pregnancy or the puerperium |
Mental disorders during pregnancy, childbirth and the puerperium |
Mental disorder during pregnancy, childbirth or the puerperium NOS |
Mental disorders during pregnancy, childbirth and the puerperium |
Mental disorders NOS |
Mental disorder |
Mental disorders NOS |
Mental disorder |
Mental disorders NOS |
Mental disorder |
Mental disorders NOS |
Mental disorder |
Mental handicap |
Intellectual disability |
Mental handicap (specialty) |
Intellectual disability specialty |
Mental handicap (specialty) |
Intellectual disability specialty |
Mental handicap (specialty) |
Intellectual disability specialty |
Mental handicap psychiatry department |
Intellectual disability psychiatry department (environment) |
Mental handicap psychiatry service |
Intellectual disability psychiatry service |
Mental health annual physical examination done |
Annual physical examination for people with mental illness completed |
Mental health crisis plan |
Mental health crisis plan |
Mental health personal health plan |
Mental health personal health plan |
Mental retardation |
Intellectual disability |
Mental retardation NOS |
Intellectual disability |
Mental retardation NOS |
Intellectual disability |
Mental retardation NOS |
Intellectual disability |
Mental retardation screening |
Intellectual disability screening |
Mental/developmental handicap screening |
Screening for developmental disorder (procedure) |
Mental/developmental handicap screening NOS |
Screening for developmental disorder (procedure) |
Mental/developmental handicap screening NOS |
Screening for developmental disorder (procedure) |
Menthol 35.55mg inhalant capsule |
Product containing only menthol in pulmonary dose form (medicinal product form) |
Mepacrine hydrochloride 100mg tablet |
Mepacrine hydrochloride 100 mg oral tablet |
Meperidine hydrochloride 100mg/mL injection solution ampule |
Product containing only pethidine in parenteral dose form (medicinal product form) |
Meperidine hydrochloride 50mg/5mL syrup |
Pethidine hydrochloride 10 mg/mL oral solution |
Meperidine hydrochloride 50mg/mL injection solution ampule |
Product containing only pethidine in parenteral dose form (medicinal product form) |
Meperidine hydrochloride 50mg/promethazine hydrochloride 50mg injection solution vial |
Product containing only pethidine and promethazine (medicinal product) |
Mepivacaine hydrochloride 3%/levonordefrin 1:20,000 injection solution vial |
Corbadrine 50 microgram/mL and mepivacaine hydrochloride 30 mg/mL solution for injection |
Mepivacaine hydrochloride 30mg/sodium chloride 3mg injection solution vial |
Mepivacaine only product |
Mepivacaine hydrochloride+epinephrine 2%/1:100,000 cartridge |
Adrenaline 10 microgram/mL and mepivacaine hydrochloride 20 mg/mL solution for injection |
Mepivacaine hydrochloride+epinephrine 2%/1:100,000 cartridge |
Adrenaline 10 microgram/mL and mepivacaine hydrochloride 20 mg/mL solution for injection |
Meptazinol 100mg/1mL injection |
Product containing precisely meptazinol (as meptazinol hydrochloride) 100 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Meptazinol 100mg/mL injection solution 1mL ampule |
Product containing precisely meptazinol (as meptazinol hydrochloride) 100 milligram/1 milliliter conventional release solution for injection (clinical drug) |